Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies

作者
Yen-Jung Kuo,Li-Feng Chen,Yumay Chen,Phang‐Lang Chen,Hugo You‐Hsien Lin
出处
期刊:International Journal of Molecular Sciences [Multidisciplinary Digital Publishing Institute]
卷期号:27 (9): 4120-4120 被引量:1
标识
DOI:10.3390/ijms27094120
摘要

The American Heart Association (AHA) recently formalized cardiovascular-kidney-metabolic (CKM) syndrome to characterize the systemic interplay among cardiovascular failure, chronic kidney disease (CKD), and metabolic disturbances. Despite evolving clinical management, identifying a unifying cellular driver of this multi-organ deterioration remains a critical priority. This review explores the hypothesis that mitochondrial dysfunction serves as the fundamental pathological nexus of CKM syndrome, driving the progression from early-stage metabolic risk to end-stage organ failure. We synthesize evidence demonstrating how nutrient overload and lipotoxicity precipitate a vicious cycle of bioenergetic failure. In the cardiovascular system, ATP deficiency and impaired mitophagy lead to the structural remodeling observed in both heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). In the kidney, the high mitochondrial density of proximal tubules renders them uniquely susceptible to oxidative stress and mitochondrial DNA (mtDNA) leakage, which subsequently triggers systemic inflammation. Furthermore, we analyze how established therapies-including sodium-glucose co-transporter 2 (SGLT2) inhibitors, Glucagon-like peptide-1 (GLP-1) receptor agonists, and non-steroidal mineralocorticoid receptor antagonists (MRAs)-exert organ-protective effects via mitochondrial mechanisms, promoting metabolic efficiency, reducing reactive oxygen species generation, stabilizing mitochondrial integrity, and promoting mitochondrial quality control processes. Finally, we review emerging mitochondrial-targeted strategies, such as mitoquinol, elamipretide and NAD+ boosters, which aim to restore the SIRT1-PGC-1 α signaling axis. Mitochondria function as the central engines of the CKM axis. A shift toward a mitocentric clinical model may enable earlier intervention and more precise targeting of the mechanisms driving organ crosstalk. Future success depends on multidisciplinary collaboration and the validation of mitochondrial biomarkers to advance precision medicine in CKM syndrome.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Arslanker完成签到,获得积分10
刚刚
Ximian完成签到 ,获得积分10
刚刚
zhoujuan_cip完成签到,获得积分10
刚刚
典雅初露发布了新的文献求助10
刚刚
NexusExplorer的应助被雪纷飞采纳,获得10
1秒前
1秒前
RJX完成签到,获得积分20
1秒前
sheeptime发布了新的文献求助10
1秒前
lxc完成签到,获得积分10
1秒前
化学喵完成签到 ,获得积分10
2秒前
尊敬凡旋完成签到,获得积分10
2秒前
好汉完成签到,获得积分10
2秒前
L_完成签到,获得积分10
2秒前
wanci的应助被mkl采纳,获得10
3秒前
科目三的应助被adai007采纳,获得10
3秒前
小黑之家完成签到,获得积分10
3秒前
Jsl完成签到,获得积分10
4秒前
Jasper的应助被lalala采纳,获得10
4秒前
RAN完成签到,获得积分10
4秒前
阿飞发布了新的文献求助10
4秒前
xyg完成签到,获得积分10
4秒前
Lucas的应助被小猪采纳,获得10
4秒前
4秒前
4秒前
hxy完成签到 ,获得积分10
5秒前
大模型的应助被微血管采纳,获得10
5秒前
科研痴完成签到,获得积分10
5秒前
5秒前
5秒前
仁爱的从雪完成签到,获得积分10
5秒前
6秒前
会飞的鱼完成签到,获得积分10
6秒前
win7完成签到,获得积分10
6秒前
6秒前
ZZZsy完成签到 ,获得积分10
6秒前
乌梅不乌完成签到,获得积分10
6秒前
6秒前
wwwww发布了新的文献求助10
7秒前
高高的若云完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185